Atrium Therapeutics announced a $50 million private placement with institutional investors to support development of its RNA therapies targeting heart diseases. The funding will advance their two lead product candidates and other research, extending operational cash through 2028. Shares and pre-funded warrants were sold at about $7.93 each, with the deal expected to close around October 9, 2026. This capital boost aims to accelerate Atrium's precision cardiology programs, including ongoing clinical trials for genetically driven cardiac diseases.
Atrium Therapeutics' $50 million private placement is the focus here, with Pluang's health sector data providing market context. As of Oct 08, 2026 17:11 WIB, among 100 priced health-sector US stocks on Pluang, 28 rose and 65 fell. Notable movers include TWST at USD 153.44 with a 1-day change of -1.42% and a typical hold time of 27 days, BNGO at USD 1.48 up 1.37% with a 49-day hold time, and GSK at USD 46.42 down 1.28% with a 93-day hold time and 100% buy order activity.
Dividend 15 Split Corp. has renewed its at-the-market (ATM) equity program, allowing it to issue shares to the public at prevailing market prices until November 7, 2028. This program replaces the previous one that ended in 2025 and enables the compan...
Fieldstone Bio, a synthetic biology company, was selected for the Mining Tech Accelerator program by Founders Factory and Rio Tinto. The program supports innovative technologies that improve mineral exploration and extraction, providing Fieldstone wi...
Beam Global has signed a definitive agreement to acquire ScoutDI, a company specializing in drone technology and AI-powered inspection software. The acquisition will enable Beam to manufacture ScoutDI's drone systems in the US and Europe, targeting i...
Grabar Law Office is investigating shareholder claims against four companies—Aardvark Therapeutics, Coastal Financial Corporation, Erasca, Inc., and New Era Energy & Digital—for alleged securities violations and breaches of fiduciary duties. The clai...
Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...
